Inspiration at the top.
Avail was launched in 2017 by Daniel Hawkins, a medical device industry veteran with a passion for identifying gaps in healthcare—and a track record of successfully growing businesses that transform the status quo.
Each person on our leadership team shares a vision for accelerating healthcare innovation and removing barriers to collaboration in medicine, while bringing their own experience, expertise, and passion to Avail.
Chief Executive Officer
Daniel Hawkins is the founder and CEO of Avail Medsystems, a medical technology company creating a network where medical expertise sharing can occur between healthcare professionals and experts to and from the operating room anytime, anywhere. Over the past 25 years in the medical technology field, Daniel’s mission has been to identify and close gaps that prevent patients from getting the best possible healthcare. He is an inventor on over 140 patents and applications, and has held roles in both large and emerging companies, including Advanced Cardiovascular Systems, Inc., Endologix, Restore Medical, EnteroMedics, and Intuitive Surgical. Daniel is a co-founder of Calibra Medical, acquired by Johnson & Johnson, and founder of Shockwave Medical, Inc. (NASDAQ: SWAV). Daniel has an MBA from Stanford University and a BS in Economics from The Wharton School of the University of Pennsylvania. In 2017, Daniel was honored by Goldman Sachs as one of its Top 100 Most Intriguing Entrepreneurs.
Chief Technology Officer
James, a technology executive with over twenty-five years of building enterprise and consumer software, hardware, and SaaS products, has led high-performing teams creating award-winning solutions in use today in millions of homes and offices. James was previously the Senior Vice President for Worldwide Engineering at TiVo, which recently merged with Xperi. Over his four years at TiVo, James focused on driving value and innovation to both enterprise customers and TiVo’s direct consumers. Prior to TiVo, James held leading positions with Mediaroom, owned first by Microsoft and then by Ericsson. There, his most recent role was as Vice President, Product Development, TV Platforms. Earlier in his career, he co-founded Pipal Systems, which was acquired by Lucent. James holds a BSC in Aerospace Engineering with Honors from the University of Toronto.
Chief Financial Officer
Steve has over twenty-five years of experience as a senior financial executive responsible for managing all aspects of finance, legal and human resources for privately and publicly held companies. Steve has built businesses from the ground up as well as helped to scale existing companies to the next level. Before joining Avail, Steve was the CFO at several venture-backed technology companies including Panzura, Cyphort, Edgewater Networks, Fanfare, RouteScience Technologies and Atmosphere Networks. Prior to Atmosphere, Steve held a number of finance positions at Whitetree, Integrated Process Equipment Corporation and KPMG. During his career, Steve has raised over $150 million in equity and debt from top tier investors, guided several companies to successful exits, and established strong financial infrastructure to help grow and expand companies. Steve earned his bachelor’s degree in business with a concentration in accounting from California Polytechnic State University in San Luis Obispo.
VP, Product Marketing
Amanda has over fifteen years of product management and product marketing experience in smaller organizations as well as Fortune 500 companies. Her career experience has focused on the crossfunctional development and launches of disruptive technologies within the Orthopedic, Neurosurgical, and Spine spaces. Before joining Avail, Amanda held marketing leadership roles with Zimmer Biomet’s (ZBH) Robotics Division managing their Spine and Neurosurgical Robotics, Data Technology and Solutions pipeline, and a suite of products. Before her time at Zimmer Biomet, Amanda held various roles at NuVasive, Inc. (NUVA), managing their flagship portfolio, and oversaw the development of several new procedures and technologies. Amanda began her career with Johnson and Johnson (JNJ) and has a passion for improving the healthcare landscape by delivering innovative technologies that ultimately improve patient outcomes and streamline the delivery of care for providers. Amanda holds a B.S. in Biopsychology from Tufts University.
Jerry has over twenty-six years of experience in sales, sales management, strategic sales and IDN corporate contracting. Throughout his career he has launched and sold new products and solutions across the entire spectrum of the cardiovascular service line, including C.R. Bard’s (BCR) Interventional Cardiology and Electrophysiology divisions, Arterial Vascular Engineering’s entrance into the coronary stent market, and the entire portfolio of Medtronic’s (MDT) Cardiovascular Group’s product launches over the last eight years. Jerry holds a B.S. in Finance from University of Nevada, Las Vegas and an MBA from Arizona State University.
VP, Field Operations
Jack has over twenty-five years of dynamic global expertise, including a depth of technical and general management leadership experience at Medtronic (MDT). He has an impressive track record of building high performing teams and is known for his relentless focus on improving patient outcomes and delivering exceptional customer experience. From software-based solutions and implementations to innovative medical devices, Jack has led from concept to successful commercialization. He holds a M.S. in Management of Technology from University of Minnesota as well as a B.S. in Mechanical Engineering from the University of Wisconsin.
Trish has nearly thirty years’ experience leading operations functions in multiple industries. Most recently, she served as Vice President of Operations at Stryker (formerly ZipLine Medical), commercializing non-invasive wound closure solutions. Previously, Trish was Vice President of Operations at Pulmonx where she led Manufacturing, Quality, and Supply Chain for the company’s diagnostic device and therapeutic implant products for Interventional Pulmonology. Before Pulmonx she served as Vice President of Materials Management at ArthroCare Corporation, scaling the global logistics infrastructure and launching a greenfield manufacturing facility in Costa Rica. Prior, Trish spent fifteen years in the automotive industry, predominantly with Ford Motor Company in roles of increasing responsibility in Product Development, Process Engineering, and Supply Chain. Trish holds a BS in Mechanical Engineering from the University of Michigan and an MBA in Finance from the University of Michigan-Dearborn.
At every successful company you’ll find an exceptional board. Avail is no exception. Complementing our leadership team and contributing significant expertise in finance, healthcare, and disruptive technology, meet the Avail Board of Directors.
Daniel has over 25 years of experience in executive management, marketing, product management and business development roles in both large and emerging medical device companies including Advanced Cardiovascular Systems, Inc. (ABT), Endologix (ELGX), Restore Medical (MDT) and EnteroMedics (ETRM) and Intuitive Surgical (ISRG). He is a Co-founder of Calibra Medical (JNJ) and Founder/CEO of Shockwave Medical (SWAV) where he led the company from concept to multiple regulatory approvals, built the company to 96 people, initiated commercialization in multiple countries and successfully raised over $100M. Daniel holds an MBA from Stanford, a B.S. in Economics from Wharton and is a named inventor on over 140 patents and applications including the foundational patents for both Calibra Medical and Shockwave Medical. In 2017, Daniel was honored by Goldman Sachs as one of its Top 100 Most Intriguing Entrepreneurs.
Peter co-founded Lux Capital with the idea that in order to have the biggest impact on the future, one should support the most scientifically and technologically ambitious ventures. Peter led Lux’s investments in Auris Health (acquired by Johnson & Johnson (JNJ) for up to $6.05 billion, making it one of top 10 VC-backed private M&A transactions of all-time), Lux Research (acquired by Private Equity), Luxtera (acquired by Cisco (CSCO) for $660 million), and SiBEAM (acquired by Silicon Image (SIMG)). Current investments include Avail, Bright Machines, Everspin Technologies (MRAM), Flex Logix, Halo Neuroscience, Matterport, Ripcord, Transphorm, and Vium. In 2003, Peter led the spin-off of Lux Research. As its founding CEO, he helped build Lux Research into the leading emerging-technology research firm. Peter began his career at Lehman Brothers, where he worked in the firm’s top-ranked Equity Research group. He was a Chancellor’s Scholar and graduated cum laude from Syracuse University’s Newhouse School, and was the Founding President of its first venture organization, Future Business Leaders and Entrepreneurs. He has been a guest on CNBC and Bloomberg TV, and speaker at Columbia, Cornell, MIT, Stanford, Yale, and the National Science Foundation.
Fred Moll, M.D.
Frederic H. Moll, M.D. is the Chief Development Officer for Johnson & Johnson (JNJ) Medical Devices Companies. Dr. Moll co-founded Auris where he served as its CEO before it was acquired by Johnson & Johnson. Prior to Auris, Dr. Moll was a founder of three public companies; Hansen Medical (HNSN), Restoration Robotics (HAIR) and Intuitive Surgical (ISRG). Prior to Intuitive, he served as a founder and medical director of Origin Medsystems, acquired by Eli Lily (LLY), and Endotherapeutics, acquired by United States Surgical. Dr. Moll is a distinguished and prolific medical device entrepreneur and has more than 20 years of medical device and high technology experience. He holds an MD from the University of Washington School of Medicine, an MS degree in Management from Stanford University’s Sloan Program and a B.A. degree from the University of California at Berkeley.
Jay has extensive experience founding and funding healthcare companies. He is a Managing Director with De Novo Ventures and serves as a Lecturer in Management at the Stanford Graduate School of Business and Co-Director of the graduate class in Biodesign Innovation. He was founding CEO of Origin Medsystems, a venture funded medical technology start-up acquired by Eli Lilly & Company (LLY). After Lilly formed Guidant, he joined the Management Committee and served as President of several divisions, including the Minimally-Invasive Surgery Group and Heart Rhythm Technologies. He also co-founded Gynecare, which went public and was later acquired by Johnson & Johnson (JNJ). At Guidant, Jay formed and led Compass, Guidant’s corporate business development and new ventures group, where he was directly involved in the acquisition of two public companies and led venture investments in fourteen companies including Impella (acquired by Abiomed (ABMD)) and Intuitive Surgical (ISRG). Prior to founding Origin, Jay held management positions in several start-ups, including Microgenics Corporation (acquired by Boehringer Mannheim), and was a consultant with McKinsey & Company (MTRX). He has served as a board member for both private and public MedTech companies and has been an active advisor and faculty member for the Kauffman Labs program that is dedicated to educating and training founders. Jay holds an MBA from Harvard Business School and an undergraduate degree from Stanford University.